FindTrial
Sign In

Neoadjuvant Therapy of Locally Advanced Gastric Carcinoma by Green Tea Extract and XELOX: a prospective randomized controlled trial

Neoadjuvant Therapy of Locally Advanced Gastric Carcinoma by Green Tea Extract and XELOX: a prospective randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014296
Enrollment
Unknown
Registered
2018-01-04
Start date
2018-01-01
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

EGCG+chemotherapy group:EGCG(epigallocatechin gallate) + chemotherapy
Control group:chemotherapy

Sponsors

Cancer Hospital of Shantou University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 18 to 80 years male or Female; 2. Pathologic diagnosis of gastric carcinoma; 3. cT3-4/N+ by the CT scan; 4. ECOG scor 0-1.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or Breast-feeding women; 2. Distant metastasis; 3. Accepted chemotherapy or radiotherapy once; 4. suffered other cancer last five years; 5. Exist serious cardiopulmonary disease; 6. Trial drug allergy.

Design outcomes

Primary

MeasureTime frame
pCR rate;—

Secondary

MeasureTime frame
3 years Disease-free-survival;—

Countries

China

Contacts

Public ContactLin Jiarui

Cancer Hospital of Shantou University Medical College

zljr@163.com+86 13794112671

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026